SFDA exposes 14 illegal drug websites

SFDA exposes 14 illegal drug websites

 
The State Food and Drug Administration (SFDA) recently issued 2010 Second Safety Warning Announcement Regarding Buying Medicines Online and exposed 14 websites releasing false drug information and selling counterfeit or substandard drugs. SFDA has turned the illegal websites over to relevant authorities to investigate and punish according to law.
 

Suggested Articles

The eight-year deal will initially cover lupus drug Benlysta and could expand to other GSK specialty-care products in the future.

Amarin had big plans for Vascepa after a big label expansion last year, but it lost a patent fight—and now a generic has won FDA approval.

Intercept Pharmaceuticals, eager to market its potential nonalcoholic steatohepatitis medicine obeticholic acid, will have to keep waiting.